Approval · Notice of Compliance 801 · 2001
IMURAN: Notice of Compliance 801
Issued November 13, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 801
- Date
- November 13, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To reinstate 50mg/vial injection which was originally cleared march 24, 1974 but never sold in canada
- Therapeutic class
- Immunosuppressive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMURAN | 02244895 | Dormant |
Medicinal ingredients
- AZATHIOPRINE SODIUM 50 MG per VIAL